Clinical Management Update of Oral Leukoplakia: A Review From the American Head and Neck Society Cancer Prevention Service
Head & Neck · 2025-02 · 47 (2) · 733-741
DOI: 10.1002/hed.28013 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Head & Neck, online erschienen am 25.11.2024. Verfasst von James C Gates und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Leukoplakia, Oral, Mouth Neoplasms. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Oral potentially malignant disorders (OPMDs) occur in up to 4%–5% of the population, of which oral leukoplakia (OL) is the most common subtype. Predicting high‐risk OL remains a challenge. Early diagnosis and effective treatment are thought to be of paramount importance to improve outcomes.
Methods
We searched PubMed and Clinicaltrials.gov data for updates in the clinical management of OL from 2015 to current.
Results
Recent publication of large cohorts of patients with OL aids in counseling patients regarding risk of malignant transformation. Management for OL includes surveillance, excision, and laser surgery, as well as local and systemic approaches to chemoprevention. Several new entities show promise regarding candidate biomarkers, chemoprevention agents, and diagnostic adjuncts, though all require further validation.
Conclusion
This update serves to further inform clinical management of OL and provide impetus for future investigations. Trial Registration NCT00099021, NCT00951379, NCT05727761, NCT05727761
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Otolaryngology-Head and Neck Surgery, UC Davis Health, Sacramento, California, USA.
- Department of Otolaryngology-Head and Neck Surgery, University of Kansas School of Medicine, Kansas City, Kansas, USA.
- Department of Otorhinolaryngology-Head and Neck Surgery, Hospital of the University of Pennsylvania and Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
- Department of Otolaryngology, UT Southwestern Medical Center, Dallas, Texas, USA.
- Department of Oral and Maxillofacial Pathology, Penn Dental Medicine and Department of Cutaneous Biology, Perlman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Marianne Abouyared, Andrew Day
Zitieren
APA
Gates, J. C., Abouyared, M., Shnayder, Y., Farwell, D. G., Day, A., Alawi, F., Moore, M., Holcomb, A. J., Birkeland, A., & Epstein, J. (2025). Clinical Management Update of Oral Leukoplakia: A Review From the American Head and Neck Society Cancer Prevention Service. Head & Neck, 47(2), 733-741. https://doi.org/10.1002/hed.28013
Vancouver
Gates JC, Abouyared M, Shnayder Y, Farwell DG, Day A, Alawi F, et al. Clinical Management Update of Oral Leukoplakia: A Review From the American Head and Neck Society Cancer Prevention Service. Head & Neck. 2025;47(2):733-741. doi:10.1002/hed.28013
BibTeX
@article{Gates2025,
author = {Gates, James C and Abouyared, Marianne and Shnayder, Yelizaveta and Farwell, D Gregory and Day, Andrew and Alawi, Faizan and Moore, Michael and Holcomb, Andrew J and Birkeland, Andrew and Epstein, Joel},
title = {Clinical Management Update of Oral Leukoplakia: A Review From the American Head and Neck Society Cancer Prevention Service},
journal = {Head & Neck},
year = {2025},
volume = {47},
number = {2},
pages = {733--741},
doi = {10.1002/hed.28013}
}
EUVIMED